ONYX PHARMACEUTICALS INC Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ONYX PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$114.52 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2013-06-30 was -$3.35M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2013-03-31 was -$111.17M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-12-31 was -$100.99M, a 177.72% decline year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-09-30 was -$42.51M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was -$230.48M, a 555.99% decline from fiscal 2011.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2011 was $50.55M, a 78.25% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2010 was $28.36M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$114.52M 10-Q · filed 2013-08-09 | -$215.52M derived: sum of 3 quarters · filed 2013-08-09 | -$258.03M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | -$111.17M 10-Q · filed 2013-05-08 | -$212.17M derived: sum of 2 quarters · filed 2013-05-08 | -$254.68M derived: sum of 3 quarters · filed 2013-05-08 | -$297.29M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | -$100.99M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$143.50M derived: sum of 2 quarters · filed 2013-02-28 | -$186.12M derived: sum of 3 quarters · filed 2013-08-09 | -$230.48M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$42.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$85.12M derived: sum of 2 quarters · filed 2013-08-09 | -$129.49M 10-Q · filed 2012-11-02 | $465.00K derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | -$42.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$86.98M 10-Q · filed 2013-08-09 | $42.97M derived: sum of 3 quarters · filed 2013-08-09 | |
| 2012-03-31 | -$44.36M 10-Q · filed 2013-05-08 | $85.59M derived: sum of 2 quarters · filed 2013-05-08 | ||
| 2011-12-31 | $129.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $50.55M 10-K · filed 2013-02-28 | ||
| 2011-09-30 | -$79.41M 10-Q · filed 2012-11-02 | |||
| 2010-12-31 | $28.36M 10-K · filed 2013-02-28 |